Process View
Any process that stops, prevents, or reduces the frequency, rate or extent of insulin-like growth factor receptor signaling.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative regulation of insulin like growth factor receptor signaling pathway"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.884 | ||
| WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 0.748 | ||
| IGF2 | insulin-like growth factor 2 (somatomedin A) | 0.695 | ||
| BMPR1B | bone morphogenetic protein receptor, type IB | 0.479 | ||
| INO80B | INO80 complex subunit B | 0.437 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.374 | ||
| C17orf28 | chromosome 17 open reading frame 28 | 0.183 | ||
| NOG | noggin | 0.171 | ||
| SORBS3 | sorbin and SH3 domain containing 3 | 0.122 | ||
| FSTL1 | follistatin-like 1 | 0.121 | ||
| COL1A1 | collagen, type I, alpha 1 | 0.107 | ||
| WFIKKN1 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1 | 0.084 | ||
| SPDEF | SAM pointed domain containing ets transcription factor | 0.076 | ||
| FBLN1 | fibulin 1 | 0.070 | ||
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.070 | ||
| ADAM12 | ADAM metallopeptidase domain 12 | 0.064 | ||
| SORBS1 | sorbin and SH3 domain containing 1 | 0.056 | ||
| BMP2 | bone morphogenetic protein 2 | 0.053 | ||
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.039 | ||
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.038 | ||
| PTRF | polymerase I and transcript release factor | 0.034 | ||
| IGF1 | insulin-like growth factor 1 (somatomedin C) | 0.029 | ||
| EHD2 | EH-domain containing 2 | 0.028 | ||
| BMP4 | bone morphogenetic protein 4 | 0.026 | Human | |
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.026 | ||
| HSPG2 | heparan sulfate proteoglycan 2 | 0.025 | ||
| IGFBP2 | insulin-like growth factor binding protein 2, 36kDa | 0.023 | Human | |
| PRKCDBP | protein kinase C, delta binding protein | 0.020 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.020 | ||
| PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.019 | ||
| RTKN | rhotekin | 0.018 | ||
| HAND1 | heart and neural crest derivatives expressed 1 | 0.018 | ||
| LTBP3 | latent transforming growth factor beta binding protein 3 | 0.018 | ||
| PLAT | plasminogen activator, tissue | 0.017 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.017 | ||
| ST8SIA2 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2 | 0.017 | ||
| CXCL14 | chemokine (C-X-C motif) ligand 14 | 0.017 | ||
| DLG5 | discs, large homolog 5 (Drosophila) | 0.017 | ||
| GAS1 | growth arrest-specific 1 | 0.016 | ||
| FST | follistatin | 0.016 | ||
| RBPMS | RNA binding protein with multiple splicing | 0.016 | ||
| SOCS7 | suppressor of cytokine signaling 7 | 0.016 | ||
| FOXF1 | forkhead box F1 | 0.016 | ||
| MYL9 | myosin, light chain 9, regulatory | 0.016 | ||
| FMOD | fibromodulin | 0.016 | ||
| LAMB2 | laminin, beta 2 (laminin S) | 0.015 | ||
| MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 0.015 | ||
| SFRP4 | secreted frizzled-related protein 4 | 0.014 | ||
| PDLIM4 | PDZ and LIM domain 4 | 0.014 | ||
| RARG | retinoic acid receptor, gamma | 0.014 | ||
| TGFB1I1 | transforming growth factor beta 1 induced transcript 1 | 0.014 | ||
| COL4A2 | collagen, type IV, alpha 2 | 0.013 | ||
| HTRA1 | HtrA serine peptidase 1 | 0.013 | ||
| EFNB3 | ephrin-B3 | 0.013 | ||
| FHL2 | four and a half LIM domains 2 | 0.013 | ||
| RAB3IL1 | RAB3A interacting protein (rabin3)-like 1 | 0.013 | ||
| C10orf116 | chromosome 10 open reading frame 116 | 0.013 | ||
| CD34 | CD34 molecule | 0.013 | ||
| TAGLN | transgelin | 0.012 | ||
| ISLR | immunoglobulin superfamily containing leucine-rich repeat | 0.012 | ||
| GPC3 | glypican 3 | 0.012 | ||
| BMP6 | bone morphogenetic protein 6 | 0.012 | Human | |
| SOSTDC1 | sclerostin domain containing 1 | 0.012 | ||
| FLNC | filamin C, gamma | 0.012 | ||
| TF | transferrin | 0.012 | ||
| EDN1 | endothelin 1 | 0.012 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.012 | ||
| AHNAK2 | AHNAK nucleoprotein 2 | 0.012 | ||
| FGF4 | fibroblast growth factor 4 | 0.012 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.011 | ||
| PRRX2 | paired related homeobox 2 | 0.011 | ||
| COPZ2 | coatomer protein complex, subunit zeta 2 | 0.011 | ||
| CXCL12 | chemokine (C-X-C motif) ligand 12 | 0.011 | ||
| APOD | apolipoprotein D | 0.011 | ||
| PITX2 | paired-like homeodomain 2 | 0.011 | ||
| GAS6 | growth arrest-specific 6 | 0.011 | ||
| SOD3 | superoxide dismutase 3, extracellular | 0.011 | ||
| C1R | complement component 1, r subcomponent | 0.011 | ||
| WISP2 | WNT1 inducible signaling pathway protein 2 | 0.011 | ||
| ITGA3 | integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | 0.011 | ||
| MYOC | myocilin, trabecular meshwork inducible glucocorticoid response | 0.011 | ||
| TPM2 | tropomyosin 2 (beta) | 0.011 | ||
| GSTM5 | glutathione S-transferase mu 5 | 0.010 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.010 | ||
| ETNK2 | ethanolamine kinase 2 | 0.010 | ||
| NR2F2 | nuclear receptor subfamily 2, group F, member 2 | 0.010 | ||
| INHBB | inhibin, beta B | 0.010 | ||
| SLC16A2 | solute carrier family 16, member 2 (monocarboxylic acid transporter 8) | 0.010 | ||
| SH3D19 | SH3 domain containing 19 | 0.010 | ||
| SCUBE2 | signal peptide, CUB domain, EGF-like 2 | 0.010 | ||
| GLIS2 | GLIS family zinc finger 2 | 0.010 | ||
| BMP7 | bone morphogenetic protein 7 | 0.010 | Human | |
| NKX3-2 | NK3 homeobox 2 | 0.010 | ||
| WNT11 | wingless-type MMTV integration site family, member 11 | 0.010 |